IRS Grants Tech, Pharma a Tax Break Boost From Trump Deduction
The IRS has granted a significant tax break to tech and pharmaceutical companies, allowing them to benefit from President Trump's research and development (R&D) deduction without increasing their tax bills under the Biden administration's 15% minimum tax. This decision ensures that these large corporations can continue to enjoy the tax benefits of the R&D deduction, despite the new minimum tax. The move has been criticized by some as favoring big businesses and potentially reducing the expected revenue from the minimum tax. However, the IRS justifies the decision as necessary to maintain the intended incentives for companies to invest in R&D, which is seen as crucial for economic growth and innovation. The article highlights the ongoing debate around corporate taxation and the balancing act between supporting businesses and ensuring fair contribution to public revenues.
Source: For the complete article, please visit the original source link below.
